Radiation Therapy for Meningiomas
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 139
Special Issue Editors
Interests: brain tumors; cranial base tumors; proton therapy; stereotactic radiosurgery; meningioma; glioma; brain metastases; ocular tumors; substance use disorder
2. Fred Hutchinson Cancer Center, 1570 N 115th St, Seattle, WA 98133, USA
Interests: brain tumors; cranial base tumors; proton therapy; stereotactic radiosurgery; meningioma; glioma; brain metastases; ocular tumors; health disparities
Special Issue Information
Dear Colleagues,
This Special Issue is dedicated to the radiation therapy management of meningiomas. We welcome submissions that collectively aim to best characterize current best practices in integrating the role of radiation therapy in the management of patients with meningioma. We welcome both high-quality clinical experiences and molecular advancements in diagnosis, prognosis, and advancing treatment. Basic science and translational work that contribute to the development of new promising integrated therapies will be strongly considered. Radiation treatments that are both effective and preserve quality of life and are possibly more cost-effective are of interest. Some topics of interest include proton therapy, other particle therapy, radiopharmaceuticals, and immune modulation to enhance the radiotherapy effect.
Dr. Helen A. Shih
Dr. Lia M. Halasz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiation therapy
- proton radiation
- particle therapy
- theranostics
- brachytherapy
- molecular features
- advance imaging
- late toxicities
- quality of life
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
